These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1711704)

  • 21. Further studies of the role of opioid receptors in the nigra in the morphine withdrawal syndrome.
    Baumeister AA; Richard AL; Richmond-Landeche L; Hurry MJ; Waguespack AM
    Neuropharmacology; 1992 Sep; 31(9):835-41. PubMed ID: 1359441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ketanserin and pirenperone attenuate acute morphine withdrawal in rats.
    Neal BS; Sparber SB
    Eur J Pharmacol; 1986 Dec; 132(2-3):299-304. PubMed ID: 3816979
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphodiesterase inhibitors potentiate opiate-antagonist discrimination by morphine-dependent rats.
    Holtzman SG
    Pharmacol Biochem Behav; 1989 Aug; 33(4):875-9. PubMed ID: 2482511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Absence of quasi-morphine withdrawal syndrome in adenosine A2A receptor knockout mice.
    Bilbao A; Cippitelli A; Martín AB; Granado N; Ortiz O; Bezard E; Chen JF; Navarro M; Rodríguez de Fonseca F; Moratalla R
    Psychopharmacology (Berl); 2006 Apr; 185(2):160-8. PubMed ID: 16470403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in morphine-dependent mice.
    Zhang G; Wu X; Zhang YM; Liu H; Jiang Q; Pang G; Tao X; Dong L; Stackman RW
    Neuropharmacology; 2016 Feb; 101():246-54. PubMed ID: 26432939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of acute morphine withdrawal on ultrasonic vocalizations in adult rats: unchanged 50-kHz call rate and altered subtype profile.
    Lin YC; Zhao LL; Clarke PBS
    Psychopharmacology (Berl); 2018 Jul; 235(7):1945-1953. PubMed ID: 29663018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats.
    Gellert VF; Sparber SB
    J Pharmacol Exp Ther; 1977 Apr; 201(1):44-54. PubMed ID: 557543
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of cyclic AMP by the mu-opioid receptor in human neuroblastoma SH-SY5Y cells.
    Yu VC; Eiger S; Duan DS; Lameh J; Sadée W
    J Neurochem; 1990 Oct; 55(4):1390-6. PubMed ID: 1697894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation.
    Picker MJ; Negus SS; Powell KR
    Psychopharmacology (Berl); 1991; 103(1):129-35. PubMed ID: 1848712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yohimbine exacerbates and clonidine attenuates acute morphine withdrawal in rats.
    Dwoskin LP; Neal BS; Sparber SB
    Eur J Pharmacol; 1983 Jun; 90(2-3):269-73. PubMed ID: 6683657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.
    Sobor M; Timár J; Riba P; Friedmann T; Király KP; Gyarmati S; Al-Khrasani M; Fürst S
    Brain Res Bull; 2011 Jan; 84(1):53-60. PubMed ID: 20934489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
    Fan LW; Tanaka S; Tien LT; Ma T; Rockhold RW; Ho IK
    Brain Res Bull; 2002 Jun; 58(2):149-60. PubMed ID: 12127012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opioid withdrawal for 4 days prevents synaptic depression induced by low dose of morphine or naloxone in rat hippocampal CA1 area in vivo.
    Dong Z; Han H; Cao J; Xu L
    Hippocampus; 2010 Feb; 20(2):335-43. PubMed ID: 19437411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
    Stinus L; Cador M; Zorrilla EP; Koob GF
    Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Response rate decreasing effects of naloxone during chronic sucrose availability.
    Kroll C; Fischer BD
    Behav Pharmacol; 2017 Aug; 28(5):401-404. PubMed ID: 28418942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions of naloxone with morphine, amphetamine and phencyclidine on fixed interval responding for intracranial self-stimulation in rats.
    Schaefer GJ; Michael RP
    Psychopharmacology (Berl); 1990; 102(2):263-8. PubMed ID: 2274609
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Co-treatment with MK-801 potentiates naloxone-precipitated morphine withdrawal in the isolated spinal cord of the neonatal rat.
    Bell JA; Beglan CL
    Eur J Pharmacol; 1995 Dec; 294(1):297-301. PubMed ID: 8788444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yohimbine co-treatment during chronic morphine administration attenuates naloxone-precipitated withdrawal without diminishing tail-flick analgesia in rats.
    Taylor JR; Lewis VO; Elsworth JD; Pivirotto P; Roth RH; Redmond DE
    Psychopharmacology (Berl); 1991; 103(3):407-14. PubMed ID: 2057541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT; Little PJ; Kuhn CM
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Subchronic Intravenous Morphine Infusion and Naloxone-Precipitated Morphine Withdrawal on P-gp and Bcrp at the Rat Blood-Brain Barrier.
    Chaves C; Gómez-Zepeda D; Auvity S; Menet MC; Crété D; Labat L; Remião F; Cisternino S; Declèves X
    J Pharm Sci; 2016 Jan; 105(1):350-8. PubMed ID: 26554626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.